Medical/Pharmaceuticals
Asieris Appoints Dr. Alice Chen as Vice President, Discovery Biology and Head of Translational Research
SHANGHAI, Sept. 22, 2021 /PRNewswire/ -- Asieris Pharmaceuticals announced the appointment of Dr.Alice Chen as Vice President, Discovery Biology and Head of Translational Research with effect fromSeptember 20, 2021. She will report to Dr.Kevin Pan, Founder and CEO of Asieris. Alice has over 20 ...
New Therapy to Treat Advanced Small Cell Lung Cancer ZEPZELCA® (lurbinectedin) Approved in Singapore
Highlights: * ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20 years * ZEPZELCA provisional approval represents an important advance for adult patients whose metastatic SCLC has progressed on or after platinum-...
Urotronic Inc., Announces Completion of the First Optilume(R) Procedure in Asia
The Optilume® Drug Coated Balloon is a novel, minimally invasive technology for the treatment of urethral stricture. MINNEAPOLIS, Sept. 22, 2021 /PRNewswire/ -- Urotronic, Inc., a Minnesota based medical device company, today announced the first Optilume® Drug Coated Balloon procedure for the tr...
Dr. Ivan Puah Sees An Increasing Number Of Patients Seeking Liposuction Correction Surgeries In Singapore
SINGAPORE, Sept. 22, 2021 /PRNewswire/ -- Dr Ivan Puah, an MOH-accredited liposuction doctor and Medical Director of Amaris B. Clinic, has seen a surge of patients seeking correction on their previously done liposuction from other cosmetic surgery clinics. Liposuction is a surgical techniqu...
1cm "Lasso" Technique for Ankle Ligament Reconstruction, Co-developed by Dr James Wee from Oxford Orthopaedics
SINGAPORE, Sept. 22, 2021 /PRNewswire/ -- Ankle Ligament Reconstruction Ankle Ligament Reconstruction is the surgical treatment of ankle injuries or damaged ankle ligaments to restore stability and function. Ankle sprains make up about half of all sports-related injuries and also commonly occurs...
LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.
LILLE, France, Sept. 22, 2021 /PRNewswire/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack® assisted system, the LUMESEAL® laser platform. Designed to enhance ease-of-use and to provide greater precision...
Koji Tanabe, CEO of I Peace, Inc. honored by World Biz Magazine with "Top 100 Innovation CEO" Award
PALO ALTO, Calif., Sept. 21, 2021 /PRNewswire/ -- Koji Tanabe, Founder and CEO
of I Peace, Inc. (https://www.ipeace.com
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
RALEIGH, N.C., Sept. 21, 2021 /PRNewswire/ -- Mayne Pharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved LEXETTE® (halobetasol propionate) foam, 0.05% for use in adolescents. LEXETTE, a super potent topical corticosteroid, is now approved for the treatment ...
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
The solution offers superior ease of formulation, potential application versatility, and more comprehensive immune support compared to probiotics and other immune health ingredients SANTA CLARA, Calif., Sept. 21, 2021 /PRNewswire/ -- Based on its recent analysis of the North American immune hea...
Farrer Park Hospital Enhances Dementia services to Better Guide Management and Care Plan for People with Dementia
SINGAPORE, Sept. 21, 2021 /PRNewswire/ -- Farrer Park Hospital
Fullerton Health launches DigiHealth Kiosk to improve accessibility and affordability of healthcare for Migrant Workers
SINGAPORE, Sept. 21, 2021 /PRNewswire/ -- The COVID 19 Pandemic has shown the
importance of primary care for all segments of society, including Migrants
Workers.
Novavax to Participate in Fireside Chat at Devex @ UNGA 76
GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing and commercializing next-generation vaccines for serious infectious diseases, today announced thatJohn J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Busin...
RhoVac announces the completion of patient recruitment for the BRaVac clinical phase IIb study of RV001 in prostate cancer
STOCKHOLM, Sept. 21, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today onSep 20th , 2021, that its clinical phase IIb study of lead drug candidate RV001 in prostate cancer, BRaVac, is deemed fully recruited and that no additional patients will be ...
Alterity Announces Presentation of Biomarker Data at the International Parkinson and Movement Disorder Society Congress 2021
MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that data was present...
ZEISS Introduces a Series of Major Innovations and Industry-First Software Applications as Part of the ZEISS Medical Ecosystem
A fully connected and integrated approach keeps ZEISS at the forefront of ophthalmology with new data management innovations across devices, workflow solutions and software applications. JENA, Germany and DUBLIN, Calif., Sept. 20, 2021 /PRNewswire/ -- At ZEISS Innovation Week,September 21- 23, 2...
PharmAbcine to Participate in BIO-Europe 2021
DAEJEON, South Korea, Sept. 20, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, announced today that the Company will virtually participate in the 27th annual BIO-Europe which will tak...
CStone presents clinical data from the China registrational bridging study on ivosidenib in patients with relapsed/refractory acute myeloid leukemia (R/R AML) with a susceptible IDH1 mutation at the 2021 ESMO Congress
* The data showed that ivosidenib demonstrated clinical efficacy in the treatment of Chinese adults with R/R AML with a susceptible IDH1 mutation. And ivosidenib was well tolerated and had a manageable safety profile * In August 2021, the National Medical Products Administration (NMPA) of Chin...
Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial
* Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety Disorder * Phase 2 clinical trial on target to start by end of 2021 and expected to read out topline data by end of 2022 ADELAIDE, Australia, Sept....
P&G partners with Philippine Red Cross for COVID-19 Bakuna Buses in CALABARZON
MANILA, Philippines, Sept. 20, 2021 /PRNewswire/ -- Procter & Gamble (P&G)
Philippines continues stepping up as a force for good by supporting the
Philippine Red Cross (PRC) mission to assist in the government's national
COVID-19 vaccination program.
India Ministry of Health and Family Welfare Approves Exablate Neuro Focused Ultrasound Platform
HAIFA, Israel and MIAMI, Fla., Sept. 20, 2021 /PRNewswire/ -- Insightec
Week's Top Stories
Most Reposted
Agoda Opens New Office at One Bangkok, Enhancing Its Technology Hub in Thailand
[Picked up by 321 media titles]
2026-04-09 13:00Visa Opens the Door to AI-Driven Shopping for Businesses Worldwide
[Picked up by 312 media titles]
2026-04-09 09:00Tata Power Collaborates with Databricks to Build Future-Ready Data and AI Platform to Accelerate Energy Transition
[Picked up by 302 media titles]
2026-04-10 11:13iQIYI to Open Its First Central China Theme Park in Wuhan, Continuing to Bring IP Value Beyond the Screen
[Picked up by 288 media titles]
2026-04-10 11:38OneQode, Hitachi Vantara & Cylix Form Strategic Alliance to Launch Sovereign AI Factory Initiative
[Picked up by 284 media titles]
2026-04-08 08:00